Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122664) titled 'Observation study on the efficacy and safety of tolansulfonic acid remimazolam in induction and maintenance therapy regimens in adult surgery' on April 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shaoxing People's Hospital
Condition:
None
Intervention:
Remimazolam group:Anesthesia induction with Remimazolam Tosilate (0.2-0.3 mg/kg, intravenous injection) and maintenance by continuous infusion (at a rate of 0.2-3.0 mg/kg/h), combined with Sufentanil and Cisatracurium (for induction) as well as Remifentanil and Sevoflurane (for maintenance).
Recruitment Status: Not Recruiti...